LifeApps Brands Inc (OTCMKTS:LFAP) Rockets Up The Charts

LifeApps Brands Inc (OTCMKTS:LFAP) has quickly captured investor interest on the OTC Markets after shares exploded higher. The company is a new trader on the OTC Markets and looks like we're going to see a new promotion getting underway. One of the best ways for penny stock investors to make money is getting out in front of a new promotion before other investors catch wind of what's happening.LifeApps describes itself as "a leading, authorized developer, publisher and licensee for Apple iOS -- iPhone, iPod touch, and iPad -- and Android tablets on Google Play and Kindle Fire and Androids via Amazon Mobile Marketplace. LifeApps Brands is actively seeking strategic partnerships and acquisitions for products across a wide range of markets including medical, m-health and wellness."The latest news from the company is that it had contracted with First Cornerstone, based in Del Mar, California. First Cornerstone provides advisory and relationship services to public and private companies on business matters including financing strategies, business development, negotiations, and accounting and financial reporting. First Cornerstone offers the benefits of years of knowledge and experience gained from working in executive management in such industries as medical device, healthcare, biotech and technology.

The team at First Cornerstone has over 40 years in working with public and private companies on business and finance strategies, having assisted in the structuring of over $1 billion in financing, licensing, partnering and M&A transactions. Specialties include Life Sciences, medical device, health care, and high tech industries. Issues commonly facing business include needs for business plan development, financing alternatives, preparation of presentation materials, assistance with preparation for merger and acquisition or business integration, accounting and financial statement preparation and reporting, and improving the overall internal business infrastructure for growth, success and sustainability. LifeApps said:

"LifeApps is pleased to engage First Cornerstone to assist with overall business strategies and corporate development. The team at First Cornerstone brings a wealth of expertise to the company that will truly help us navigate the company through the near term and foreseeable future. First Cornerstone's broad experience across important key industries will add a valuable perspective to our Board of Directors. We look forward to benefitting from First Cornerstone's judgment and counsel."

Last week, LFAP announced that it had entered into an agreement with medical device company FemCap Inc. FemCap provides innovative FDA approved contraceptive and feminine hygiene medical device products designed for today's healthy lifestyles of engaged women. Under the agreement LifeApps has a 90-day exclusive right to purchase FemCap's operating assets used to market and sell FemCap and FemmyCycle feminine hygiene products. The LOI also includes utilizing the expertise and experience of FemCap founder Dr. Alfred Shihata. Dr. Shihata brings to the team a wealth of experience in research and development of contraceptive and feminine hygiene medical devices as well as being affiliated with Scripps Institutions of Medicine and Science in San Diego, CA and holding 6 U.S. Patents and numerous international patents, including FemCap and FemmyCycle.FemCap products include the FemCap contraceptive device and the FemmyCycle menstrual cup. These feminine contraceptive and hygiene products are clinically tested and FDA approved. The products have health and wellness benefits over traditionally used contraceptive and feminine hygiene products. Additionally, they are more environmentally friendly (reusable), safe, and easy to use while providing cost savings over traditional products in their markets. In 2015 over 1200 clinicians and clinics were on FemCap's customer list.FemCap products have both U.S. and international distribution. FemCap requires a prescription in the United States and is currently distributed via Medical Practices and is available without prescription internationally. FemmyCycle is a consumer product and is currently distributed online via Amazon.com, FemCap's website and select retailers. LifeApps says that it sees great growth potential for both products by expanding the awareness of the health benefits of these innovative products through aggressive marketing and expanded distribution options. FemCap has already seen a 41% increase in sales in the last two years with a gross profit margin of 66%. LifeApps CEO Robert Gayman said:

"LifeApps is incredibly excited to enter into this agreement with Dr. Shihata and FemCap. Dr. Shihata has created a pair of truly innovative contraceptive and feminine hygiene products that women love. LifeApps is eager to expand the marketing efforts behind these incredible products and make them more accessible to women globally. We strongly believe that the growth potential for these products is massive and LifeApps has the experience raising brand awareness to make FemCap and FemmyCycle the first choice in feminine contraceptive and hygiene products for women around the world."

Currently trading with a market cap of $1.9 million, LFAP is setting itself for a push higher. We think we're in the early innings of a lot more to come from LFAP in terms of press releases and stock price appreciation. We just urge a bit of caution as the financials for LFAP remain weak. The company reported $5 thousand in cash, $17 thousand in total assets, $456 thousand in total liabilities, $140 thousand in revenues in 2015, and a net loss of $616 thousand. We will be updating Insider Financial as soon as we know more. For continuing coverage on LFAP, sign up for our free newsletter today and get our next hot stock pick!Disclosure: We have no position in LFAP and have not been compensated for this article.